How stigma affects quality of life in men with low testosterone
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at how the stigma of having low testosterone affects men's sense of self and quality of life. By answering questionnaires, you can help doctors understand and better support men with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a man aged 18 or older.
- You have low testosterone (below 300 ng/dL) with at least one symptom, OR you have diabetes, high blood pressure, or an underactive thyroid with normal testosterone levels.
- You are under regular care at an endocrinology clinic (hormone doctor).
- You can read and understand Turkish.
- You do not have a serious active mental illness, certain chronic inflammatory diseases, or severe uncontrolled hormone problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special diet can improve symptoms of low testosterone in men. It is intended to help men with certain symptoms like a low sex drive or trouble having erections and whose blood tests show low to borderline testosterone levels.
This study looks at how testosterone therapy affects blood pressure over 24 hours in men with low testosterone. It may help you understand how this treatment could affect your heart health.
This Phase 2 study tests whether testosterone therapy can help men with chronic kidney disease who have low testosterone and related symptoms. It looks to see if treatment is safe and beneficial, while carefully checking heart, blood, prostate, and clotting risks.
This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are under active surveillance. It aims to see if treatment can help without worsening the cancer.
This trial tests a testosterone injection (XYOSTED) to see if it's safe and effective for replacing testosterone in teenage boys who have low levels due to a known medical condition. It lasts 52 weeks, with an optional 2-year follow-up.
This study looks at whether low testosterone (often called male hypogonadism) is linked to having HIV. It compares HIV-positive men with HIV-negative men to better understand what contributes to hormone problems and how common they are.
Hear when a new Hypogonadism, Male trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.